BioScience Health Innovations, Inc. (BHIC)
BHIC is quoted over the counter, not listed on an exchange. BioScience Health Innovations, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-13.
Profile
| Field | Value |
|---|---|
| Ticker | BHIC, quoted over the counter |
| SEC CIK | 0001784440 |
| OTC Markets tier | OTCID (price source, 2026-11-13) |
| SEC industry code | Services-Computer Processing & Data Preparation |
| Business address | Bluffdale, UT |
| Incorporated in | NV |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-13 |
| Cash and burn | $712K cash; operating cash flow -$384K a quarter. | Report 2026-06-30 |
| Shares outstanding | 12,027,217 (2026-11-13); 10,979,055 a year earlier; 40,792,600 three years earlier. 3y figure adjusted for split (1-for-4 overall). | Cover page 2026-11-13 |
| Reverse splits, 3 years | 1; latest 1-for-4 on 2025-09-26 | Source 2025-09-26 |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | MAC ACCOUNTING GROUP & CPAS, LLP, Midvale, Utah, United States | PCAOB Form AP 2026-04-06 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $1.0M | -$186K | -$542K | $712K | $260K | $4.5M | 10-Q 2026-08-07 |
| Q1 2026 2026-03-31 | $751K | -$230K | -$552K | $1.1M | $460K | $5.2M | 10-Q 2026-05-11 |
| Q4 2025 2025-12-31 | $1.6M | -$234K | -$101K | $662K | $0 | $5.7M | 10-K 2026-03-30 |
| Q3 2025 2025-09-30 | $1.1M | -$9K | -$340K | $1.1M | No debt tags | $4.7M | 10-Q 2025-10-27 |
| Q2 2025 2025-06-30 | $1.8M | $458K | $285K | $1.3M | No debt tags | $4.2M | 10-Q 2026-08-07 |
| Q1 2025 2025-03-31 | $1.2M | $427K | $328K | $1.0M | No debt tags | $2.8M | 10-Q 2026-05-11 |
| Q4 2024 2024-12-31 | $610K | $10K | -$50K | $663K | No debt tags | $1.8M | 10-K 2026-03-30 |
| Q3 2024 2024-09-30 | $573K | $56K | $52K | $333K | No debt tags | $1.5M | 10-Q 2025-10-27 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 1-A | 2025-11-25 |
| Latest annual report | 10-K | 2026-03-30 |
| Latest quarterly / interim | 10-Q | 2026-11-13 |
| Latest current report | 8-K | 2026-04-02 |
Source: SEC EDGAR submissions feed, 54 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier